Coding and Reimbursement
-
FDA Fully Approves Leqembi for Alzheimer’s; CMS Unclear on PET Reimbursement
Jul 10, 2023
—
The FDA has granted full approval to Leqembi (lecanemab); however, CMS has not committed to reimbursement of the needed PET scans.
-
Congress passes 2023 Consolidated Appropriations Act
Dec 29, 2022
—
On December 23, 2022, the U.S. House of Representatives passed H.R. 2617, the 2023 Consolidated Appropriations Act (also referred to as the Omnibus package) by a vote of 225-201-1.
-
CMS Publishes 2023 MPFS and Hospital OPPS Final Rule
Nov 22, 2022
—
On November 1, CMS released the 2023 Medicare Physician Fee Schedule and Hospital Outpatient Prospective payment Final Rules.
-
The U.S. Departments of Health and Human Services (HHS), Labor, and the Treasury released final rules titled “Requirements Related to Surprise Billing: Final Rules.”
Sep 13, 2022
—
The U.S. Departments of Health and Human Services (HHS), Labor, and the Treasury released final rules titled “Requirements Related to Surprise Billing: Final Rules.” Read more for highlights of the updated rules.
-
CMS releases its CY 2023 Medicare Physician Fee Schedule Proposed Rule
Jul 14, 2022
—
The Centers for Medicare and Medicaid Services (CMS) released its 2023 Medicare Physician Fee Schedule (MPFS) Proposed Rule on July 7.
-
Aetna Reverses Cardiac PET/CT Non-Coverage & Updates Policy for PSMA Therapy
Jun 27, 2022
—
SNMMI and ASNC requested that Aetna reverse its non-coverage cardiac PET/CT policy. We are thrilled to communicate that within a few days of receiving our letter, Aetna reversed the policy. Also, Aetna recently updated and published their coverage policy for PSMA imaging for PLUVICTO therapy eligibility.
-
SNMMI and Partners Request a Hearing for the FIND Act
Apr 28, 2022
—
This week, SNMMI and over 70 organizations sent a letter to House Energy and Commerce and Ways and Means Committee Leadership requesting a hearing on the Facilitating Innovative Nuclear Diagnostics (FIND) Act.
-
SNMMI Hosts AI and Patient Access Summits
Mar 28, 2022
—
On March 21-23, SNMMI hosted two summits in Bethesda, MD, on Artificial Intelligence and Barriers to Patient Access. The aim of the summits—the first of their kind for the society—was to bring together thought leaders to discuss current obstacles in the field of nuclear medicine and provide solutions. Read the highlights.
-
SNMMI Advocates for Expanded Coverage & Reimbursement of Amyloid PET
Feb 17, 2022
—
When CMS issued a national coverage determination analysis for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease, SNMMI took action.
-
SNMMI Authors Member Template Letter for SPECT/CT Coverage Denials
Jun 3, 2021
—
After many complaints from our members about SPECT/CT coverage denials from various commercial payers, SNMMI has put forth a resource members can use to contest these decisions.
-
Courtney Lawhn-Heath Awarded 2019 Henkin Fellowship
Apr 23, 2019
—
SNMMI is pleased to announce that Courtney Lawhn-Heath, MD, has been selected as the recipient of the 2019 Robert E. Henkin Government Relations Fellowship.
-
Aria Razmaria, MD, Awarded 2018 Henkin Fellowship
Apr 11, 2018
—
SNMMI and the Education and Research Foundation for Nuclear Medicine and Molecular Imaging are pleased to announce that Aria Razmaria, MD, has been selected as the recipient of the 2018 Robert E. Henkin Government Relations Fellowship.
-
FDA Issues Draft Guidances on Compounding and Repackaging Radiopharmaceuticals
Jan 11, 2017
—
The FDA issued two draft guidances that describe FDA’s proposed policies regarding the compounding and repackaging of radiopharmaceuticals for human use by state-licensed nuclear pharmacies or federal facilities, and outsourcing facilities.
-
SNMMI Develops USP Recommendations for Compounded Sterile Radiopharmaceuticals
Dec 14, 2016
—
SNMMI has developed USP Recommendations for Compounded Sterile Radiopharmaceuticals.
-
House Passes 21st Century Cures Bicameral Compromise
Dec 1, 2016
—
On Wednesday, November 30, the House passed the 21st Century Cures legislation 392-26, sending the sweeping FDA and CMS reform package to the Senate.
-
A Look at the New Administration’s Healthcare Nominees
Nov 29, 2016
—
President-elect Donald Trump’s healthcare nominees are in keeping with his promise to repeal and replace the Affordable Care Act (ACA), as well as to work with Republicans to overhaul Medicare and Medicaid significantly. Trump has selected Republican Representative Tom Price, an orthopedic surgeon from Georgia, to lead the Department of Health and Human Services and Seema Verma—president, CEO and founder of SVC, Inc., a national health policy consulting company—to serve as CMS administrator.
-
CMS Releases CY 2017 HOPPS & MPFS Final Rules - Effective January 1, 2017
Nov 3, 2016
—
CMS released the CY 2017 Final Rules for the Hospital Outpatient Prospective Payment System (HOPPS) and the Medicare Physician Fee Schedule.
